Victory Capital Management
CGON icon

Victory Capital Management’s CG Oncology CGON Stock Holding History

Victory Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472K Buy
6,645
+549
+9% +$35.9K ﹤0.01% 2086
2026
Q1 		$413K Buy
6,096
+262
+4% +$14.8K ﹤0.01% 2068
2025
Q4 		$242K Buy
5,834
+424
+8% +$17.5K ﹤0.01% 2160
2025
Q3 		$218K Sell
5,410
-11,523
-68% -$335K ﹤0.01% 2208
2025
Q2 		$440K Buy
+16,933
New +$408K ﹤0.01% 2079

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management's CGON Position: Q2 2026 in Review

Victory Capital Management increased its CG Oncology (CGON) stake by 9% in Q2 2026, buying an estimated $35.9K and bringing the position to 6,645 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #2086.

Victory Capital Management first reported a position in CGON in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Victory Capital Management held 6,645 shares of CG Oncology worth $472K as of Q2 2026.
  • Victory Capital Management bought 549 CG Oncology shares in Q2 2026, an estimated $35.9K.
  • CG Oncology made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2086 holding.
  • Victory Capital Management first reported a position in CG Oncology in Q2 2025 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.